healthcare News
Autolus shares plunge on earnings miss, negative AUCATZYL margins
CAR-T therapy costs exceeded sales in launch year as net loss triples to $90.3M
Instil Bio pivots to acquisitions after clinical program collapse
Biotech's $76.3M cash stash fuels speculative M&A strategy as internal pipeline vanishes
AstraZeneca COPD drug trials succeed as shares fall to six-week low
First-in-class IL-33 inhibitor Tozorakimab meets Phase III targets in two confirmatory studies, challenging Regeneron-Sanofi rival
Novartis to acquire Excellergy for up to $2B in allergy push
Deal adds experimental anti-IgE therapy to Swiss drugmaker's immunology portfolio amid competitive landscape for food allergy treatments
CapsoVision revenue beat overshadowed by widening losses
Medical technology company posts $13.6M fiscal year revenue but burns through $25.3M amid R&D expansion
Rani Therapeutics beats earnings as GLP-1 pill advances
Biotech firm reports narrower losses, advances obesity drug with Chugai deal bolstering balance sheet
Daré Bioscience losses widen as cash runway raises concerns
Net loss expands to $13.4M as company prepares commercial launch of DARE to PLAY
Rhythm gains on EU backing for rare obesity drug
IMCIVREE set for European approval after CHMP endorsement for hypothalamic obesity